HomeInvestors HealthPaulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves By BOMAR ENT. November 15, 2024 FacebookTwitterPinterestWhatsApp bodnarchuk/iStock via Getty Images Paulson & Co. exited its position in AngloGold Ashanti (NYSE:AU) in Q3, according to the fund’s latest 13F filing. The fund increased its stake in Madrigal Pharmaceuticals. Paulson & Co. also reduced its position in Altice USA (ATUS) in Source link Previous articlePassive Income Strategy for Stocks and Options | Covered Calls Tutorial #stocksNext articleStock market news today: Tech gains, Dow lags on heels of slowing labor market demand | 12/5/23 latest articles explore more Do you have these 5 financial accounts? #shorts #money #personalfinance 3 Magnificent S&P 500 Dividend Stock Down 35% to Buy and Hold Forever Home builders are starting to crack. DR Horton CEO issues big housing market warning. Options Trading Crash Course 2021 volume 3: The Best Guide for Beginners of the Market Psychology to Use the Right Strategies and Avoid the... Top 3 Stocks 2019 – RICH TV LIVE – Departures Capital – Whiteboard Finance – Investing Hustler Are SuperYachts at Risk? | SuperYacht Security LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.